Xu S - Search Results

1

[Antiviral activity determination of recombinant equine interferon-gamma and identification inhibited antiviral activity of monoclonal antibodies].

Bai Y, Chen W, Tong T, Zhang W, Xu S, Wang Q, Sun Q, Liu G, Bu Z, Wu D. Bai Y, et al. Among authors: xu s. Sheng Wu Gong Cheng Xue Bao. 2008 Jul;24(7):1258-62. Sheng Wu Gong Cheng Xue Bao. 2008. PMID: 18837405 Chinese.

2

[Effects of fusion gene of ubiquitin and porcine reproductive and respiratory syndrome virus M gene on the immune response in inoculated mice].

Zhang W, Tong T, Bai Y, Wang Q, Xu S, Sun Q, Tian Y, Yang T, Tong G, Wu D. Zhang W, et al. Among authors: xu s. Wei Sheng Wu Xue Bao. 2009 Jun;49(6):799-806. Wei Sheng Wu Xue Bao. 2009. PMID: 19673417 Chinese.

3

Expression, purification and monoclonal antibodies preparation of recombinant equine mature interleukin-18.

Tong T, Bai Y, Liu G, Wang Q, Zhang W, Xiao Y, Xu S, Liu N, Yang T, Wu D. Tong T, et al. Among authors: xu s. Vet Immunol Immunopathol. 2010 Aug 15;136(3-4):194-200. doi: 10.1016/j.vetimm.2010.03.002. Epub 2010 Mar 7. Vet Immunol Immunopathol. 2010. PMID: 20347490

4

[Development of sandwich ELISA for equine interferon-gamma detection].

Bai Y, Tong TG, Zhang WJ, Xu SL, Wang Q, Liu GL, Wu DL. Bai Y, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 May;24(5):464-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 18466703 Chinese.

5

Early inadequate response to biological agents portends treatment failure at 6 months in patients with psoriasis: a multicenter, prospective cohort study.

Jiang Y, Yao L, Zhong X, Huang D, Wang Y, Hu Y, Xu S, Yu Q, Li Y, Lu J, Shi Y. Jiang Y, et al. Among authors: xu s. J Am Acad Dermatol. 2025 Jan 24:S0190-9622(25)00135-5. doi: 10.1016/j.jaad.2025.01.055. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 39864747 No abstract available.

6

Lysyl oxidase nanozyme-loaded hydrogel for sustained release and promotion of diabetic bone defect regeneration.

Xu S, Zhang J, Che J, Sha Z, Zhang M, Zhang Z, Xiang T, Zhong W, Wu L, Lv G, Cai B, Xu L, Xu C, Chen Z. Xu S, et al. J Control Release. 2025 Jan 24:S0168-3659(25)00080-X. doi: 10.1016/j.jconrel.2025.01.070. Online ahead of print. J Control Release. 2025. PMID: 39864630

7

Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System.

Lin Y, Deng M, Xu S, Chen C, Ding J. Lin Y, et al. Among authors: xu s. Oncology. 2025 Jan 24:1-9. doi: 10.1159/000542989. Online ahead of print. Oncology. 2025. PMID: 39864433

8

Highly efficient recovery of total components from spent hydroprocessing catalysts (HPCs) with minimal CO₂ & SO₂ emissions.

Xu G, Wang J, Xu F, Huang G, Xu S, Wu B. Xu G, et al. Among authors: xu s. J Environ Manage. 2025 Jan 25;375:124204. doi: 10.1016/j.jenvman.2025.124204. Online ahead of print. J Environ Manage. 2025. PMID: 39864150

9

The effect of laparoscopic cholecystectomy combined with laparoscopic transcystic common bile duct exploration in treatment of cholecystolithiasis combined with choledocholithiasis.

Xu S, Deng C, Tang K, Nian G, Man Z, Yang S, Xu M. Xu S, et al. Updates Surg. 2025 Jan 25. doi: 10.1007/s13304-025-02110-7. Online ahead of print. Updates Surg. 2025. PMID: 39863823

10

[Study of the occurrence of metabolic dysfunction-associated fatty liver disease in obstructive sleep apnea hypopnea syndrome and its risk factors].

Guo YL, Zhang DY, Xu SJ, Zhang MJ, Li J. Guo YL, et al. Among authors: xu sj. Zhonghua Nei Ke Za Zhi. 2025 Feb 1;64(2):128-133. doi: 10.3760/cma.j.cn112138-20240812-00506. Zhonghua Nei Ke Za Zhi. 2025. PMID: 39863559 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,353 results

Search Page

Filters